316 related articles for article (PubMed ID: 34122413)
21. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
22. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
23. Human Coronavirus: Host-Pathogen Interaction.
Fung TS; Liu DX
Annu Rev Microbiol; 2019 Sep; 73():529-557. PubMed ID: 31226023
[TBL] [Abstract][Full Text] [Related]
24. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
Front Immunol; 2020; 11():1022. PubMed ID: 32574260
[TBL] [Abstract][Full Text] [Related]
25. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors.
Low ZY; Yip AJW; Sharma A; Lal SK
Virus Genes; 2021 Aug; 57(4):307-317. PubMed ID: 34061288
[TBL] [Abstract][Full Text] [Related]
26. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
Rokni M; Ghasemi V; Tavakoli Z
Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
[TBL] [Abstract][Full Text] [Related]
27. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms for understanding the association between TMPRSS2 and beta coronaviruses SARS-CoV-2, SARS-CoV and MERS-CoV infection: scoping review.
Chaves-Medina MJ; Gómez-Ospina JC; García-Perdomo HA
Arch Microbiol; 2021 Dec; 204(1):77. PubMed ID: 34953136
[TBL] [Abstract][Full Text] [Related]
29.
Bao R; Hernandez K; Huang L; Luke JJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
[TBL] [Abstract][Full Text] [Related]
30. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
[TBL] [Abstract][Full Text] [Related]
31. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
32. Innate and Adaptive Immune Genes Associated with MERS-CoV Infection in Dromedaries.
Lado S; Elbers JP; Plasil M; Loney T; Weidinger P; Camp JV; Kolodziejek J; Futas J; Kannan DA; Orozco-terWengel P; Horin P; Nowotny N; Burger PA
Cells; 2021 May; 10(6):. PubMed ID: 34070971
[TBL] [Abstract][Full Text] [Related]
33. Coronavirus virulence genes with main focus on SARS-CoV envelope gene.
DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Castaño-Rodriguez C; Fernandez-Delgado R; Usera F; Enjuanes L
Virus Res; 2014 Dec; 194():124-37. PubMed ID: 25093995
[TBL] [Abstract][Full Text] [Related]
34. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
İnandıklıoğlu N; Akkoc T
Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
[TBL] [Abstract][Full Text] [Related]
35. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
[TBL] [Abstract][Full Text] [Related]
36. Molecular Basis of Coronavirus Virulence and Vaccine Development.
Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
[TBL] [Abstract][Full Text] [Related]
37. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey EE; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33811184
[TBL] [Abstract][Full Text] [Related]
39. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
Marchan J
Hum Immunol; 2020; 81(10-11):588-595. PubMed ID: 32888767
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
